Capital Fund Management (CFM)
BNTX icon

Capital Fund Management (CFM)’s BioNTech BNTX Stock Holding History

Capital Fund Management (CFM)’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,700
Closed -$3.16M – 2001
2024
Q4 		$3.16M Buy
27,700
+1,700
+7% +$194K 0.01% 1306
2024
Q3 		$3.09M Sell
26,000
-3,000
-10% -$276K 0.01% 1242
2024
Q2 		$2.33M Sell
29,000
-71,600
-71% -$6.54M 0.01% 1313
2024
Q1 		$9.28M Sell
100,600
-52,400
-34% -$5.02M 0.03% 770
2023
Q4 		$16.1M Buy
153,000
+4,300
+3% +$433K 0.04% 550
2023
Q3 		$16.2M Buy
148,700
+28,600
+24% +$3.16M 0.06% 435
2023
Q2 		$13M Buy
120,100
+69,200
+136% +$7.78M 0.05% 471
2023
Q1 		$6.34M Buy
50,900
+39,700
+354% +$5.45M 0.03% 653
2022
Q4 		$1.68M Sell
11,200
-9,600
-46% -$1.48M 0.01% 999
2022
Q3 		$2.81M Sell
20,800
-16,900
-45% -$2.58M 0.02% 748
2022
Q2 		$5.62M Sell
37,700
-24,200
-39% -$3.7M 0.05% 484
2022
Q1 		$10.6M Sell
61,900
-63,400
-51% -$10.7M 0.09% 324
2021
Q4 		$32.3M Buy
125,300
+36,300
+41% +$9.94M 0.23% 96
2021
Q3 		$24.3M Buy
89,000
+64,500
+263% +$20.5M 0.18% 145
2021
Q2 		$5.49M Buy
+24,500
New +$4.62M 0.04% 531

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital Fund Management (CFM)'s BNTX Position: Q4 2024 in Review

Capital Fund Management (CFM) sold out of BioNTech (BNTX) in Q4 2024, closing a stake of 14,946 shares — an estimated $1.71M sold.

Capital Fund Management (CFM) first reported a position in BNTX in Q2 2021 and held it in 9 quarters. The position peaked at $19.5M in Q4 2021. 303 funds tracked by Wall St. Rank hold BNTX as of Q4 2024.

  • Capital Fund Management (CFM) reported no remaining BioNTech position as of Q4 2024 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 14,946 BioNTech shares in Q4 2024, an estimated $1.71M.
  • Capital Fund Management (CFM) first reported a position in BioNTech in Q2 2021 and held it in 9 quarters.
  • Capital Fund Management (CFM)'s BioNTech position peaked at $19.5M in Q4 2021.
  • 303 funds tracked by Wall St. Rank held BioNTech as of Q4 2024.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2024, filed 13 Feb 2025.